- Presentations
- 2
- Markets
- 1
Zegfrovy is a brand of Sunvozertinib marketed by Dizal Pharmaceutical, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sunvozertinib
- Brand owner
- Dizal Pharmaceutical
- Registered in
- United States
- Strengths and forms
- 150 mg tablet, 200 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Zegfrovy 150 mg tabletOral | Dizal Pharmaceutical | US FDA | Available on request |
| Zegfrovy 200 mg tabletOral | Dizal Pharmaceutical | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Zegfrovy
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.